In Depth

Alzheimer’s: drug delivery and the blood brain barrier conundrum

Era of ADCs: pharma companies innovate to stand out in a buzzing market

AbbVie’s Humira loss of exclusivity has been a missed opportunity for competitors

How NVIDIA grew with the healthcare market instead of pushing into it